ACE and COVID-19: Use of some cardiovascular medicines, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers may be associated with severe COVID-19 infection.25,27 Mehra et al. (2020) indicated that cardiovascular diseases themselves and not the use of medicines are related to increased mortality among patients hospitalized with COVID-19.